NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
3.350
+0.080 (2.45%)
At close: Oct 6, 2025, 4:00 PM EDT
3.399
+0.049 (1.47%)
After-hours: Oct 6, 2025, 7:59 PM EDT

NRx Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
8027387528166
Upgrade
Market Cap Growth
360.12%-30.71%-48.99%-73.29%328.57%1.96%
Upgrade
Enterprise Value
87313957243-
Upgrade
Last Close Price
3.352.204.6011.1047.80244.00
Upgrade
PB Ratio
--1.14-3.2610.1313.51-1.50
Upgrade
P/TBV Ratio
---10.1313.51-
Upgrade
Debt / Equity Ratio
-0.28-0.27-0.781.420.03-0.02
Upgrade
Quick Ratio
0.070.070.241.292.320.06
Upgrade
Current Ratio
0.110.150.361.662.740.06
Upgrade
Return on Equity (ROE)
----281.79%--
Upgrade
Return on Assets (ROA)
-174.88%-224.60%-104.08%-94.66%-330.91%-378.83%
Upgrade
Return on Capital (ROIC)
---224.47%-141.17%--
Upgrade
Earnings Yield
-42.44%-94.69%-78.73%-52.95%-33.11%-78.94%
Upgrade
FCF Yield
-14.96%-40.09%-56.56%-52.96%-13.41%-3.46%
Upgrade
Buyback Yield / Dilution
-61.59%-40.50%-15.20%-40.17%-36.90%-220.58%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q